← Research library

Effect of thymomimetic vilon on blood coagulation system and fibrinolisis in diabetes mellitus type 1 patients of different age

Observational study · 2006

What was studied
Type-1 diabetes patients of different ages
Main finding
The abstract reports coagulation and fibrinolysis changes during adjunctive Vilon treatment in type 1 diabetes, with weaker responses in older patients with severe disease. These are surrogate outcomes.

Reported findings and study design

Population or model Type-1 diabetes patients of different ages

Results · Primary indexed abstract, PMID 17152731.
MeasureResultComparison, timing and statistics
Coagulation / fibrinolysisReported improvement, with less pronounced effects in older, severely affected patients

Allocation, sample size and independent effect size are not established from the abstract. Biomarkers are not disease-modifying outcomes; cohort overlap remains unresolved.

Source for these results ↗ · Reviewed 2026-11-05

Study limitations and source details

Study limitations

  • The study may share participants with the 2007 diabetes publication.
  • Full methods, adverse-event reporting and independent replication remain to be appraised.

Source details

Journal publication

Europe PMC indexed citation and abstract checked. Full original paper not reviewed.

Sources checked

Citation

Uncontrolled human reportEnglish abstract

Kuznik BI, Kolesnichenko LR, Kliuchereva NN, Pinelis IuI, Ryzhak GA, Khamaeva TsB. Effect of thymomimetic vilon on blood coagulation system and fibrinolisis in diabetes mellitus type 1 patients of different age Advances in gerontology = Uspekhi gerontologii 19():107-115. PMID 17152731

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards